A 2024 survey by Médecins Sans Frontières tested 1,213 women aged 30 to 49 in rural Sokuluk district and Bishkek and found a high-risk type of human papillomavirus, the virus that causes cervical cancer, in 9.0%. HPV16 was the commonest type.
Published as "Prevalence of high-risk human papillomavirus types among women aged 30-49 years in the Chuy region, Kyrgyzstan". A cross-sectional study between January and May 2024 in two facilities in Sokuluk district and one in Bishkek, using the Xpert HPV test on cervical samples, with visual inspection with acetic acid and a questionnaire. The authors set out to establish a baseline before the national HPV vaccination programme, begun in 2022, takes full effect, and describe it as the first comprehensive data on high-risk HPV in the country.
The authors argue for scaling up cervical screening based on HPV testing alongside vaccination. WHO's 2021 profile recorded no national cervical screening programme in Kyrgyzstan.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/